Found: 3 articles
Article | Edition |
---|---|
E.V. Svechnikova (1, 2)
Review of clinical trials of the IL-23 inhibitor guselkumab. Experience of using genetically engineered biological therapy with guselkumab in a patient with severe arthropathic psoriasis
|
№8 / 2021 |
L.A. Yusupova, Z.Sh. Garaeva, E.I. Yunusova, G.I. Mavlyutova, I.I. Akhmetzyanova
Devergie’s disease
|
№8 / 2021 |
S.E. Zhufina (1), K.A. Fomin (1), E.V. Svechnikova (1, 2)
Analysis of comorbid conditions and tolerability of treatment with genetically engineered biological drugs and methotrexate in patients with psoriasis
|
№8 / 2021 |